The DEA and opponents have filed new briefs in the federal cannabis rescheduling hearing, shaping the future of marijuana policy and delivery laws nationwide.

Texas candidate James Talarico vows to fight for adult-use cannabis legalization and regulation at the federal level if elected, spotlighting national and DMV implications.

With dispensaries now active in all 11 regions, Kentucky becomes a model for equitable medical cannabis access in the South as its regulated program expands.

Top officials and legislators urge Massachusetts voters to reject an initiative that would repeal legal cannabis sales—impacting retail, delivery, and regional cannabis policy.

A majority of U.S. military veterans support legalizing cannabis for recreational and medical use, a 2026 veterans survey finds—impacting policy debates in DC, Maryland, and Virginia.

Support for former President Donald Trump is slipping among marijuana consumers as stalled federal rescheduling and policy uncertainty impact voter sentiment, especially in the DMV region.

Massachusetts and Idaho lead contrasting 2026 ballot initiatives that could reshape state retail markets and constitutional legalization limits.

An Iowa-based psychedelic church secures confidential DEA approval and state registration to import and brew ayahuasca tea, signaling new legal and cultural questions for plant medicine communities—even beyond Iowa.

Federal changes threaten Florida’s thriving hemp beverage market. The state could lead with smart THC drink rules, setting an example for national cannabis regulation.

Federal administrative law judge directs the Drug Enforcement Administration to address opponents' latest push for expanded testimony and discovery.

Patients and industry leaders allege bias in South Dakota's medical cannabis oversight, raising questions about fair representation and the future of policy.

A new study shows cannabis is the leading substance used among U.S. hikers—surpassing alcohol and psychedelics. Scientific context, safety, and DMV region implications explored.

Idahoans will decide whether only lawmakers—not voters—can legalize marijuana or other psychoactive drugs. Here’s what HJR 4 does, who backs it, and why it matters beyond Idaho.

On Ben & Jerry’s The Mix podcast, the WNBA star urged nationwide legalization, citing jobs, state revenue and a safer alternative to painkillers—raising big questions for the DMV.

State lawmakers in Tennessee held hours of hearings on a limited medical marijuana plan as the TBI opposed it and legislators challenged claims linking cannabis to violence.

DEA adds dedicated federal registration paths for state-licensed medical marijuana manufacturers, distributors, and testing labs, expanding beyond dispensaries amid ongoing Schedule III transition.

A new op-ed spotlights how Latino and immigrant workers power cannabis cultivation and retail—and why federal immigration policy and partial rescheduling still put them at risk.

Gov. Maura Healey says keep cannabis legal as Massachusetts voters face a November measure to roll back adult-use sales and home grow. Here’s what’s at stake and why DMV readers should care.

DEA’s 2026 Drugs of Abuse update says no deaths from marijuana overdose and reflects federal moves toward Schedule III for certain cannabis products. Here’s what it means in practice.

The FDA opened a 45‑day comment window on how to safely study ibogaine, seeking input on dosing, cardiac monitoring, ethics, and trial design—without touching legalization debates.